Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants

Serological studies of COVID-19 convalescent patients have identified polyclonal lineage-specific and cross-reactive antibodies (Abs), with varying effector functions against virus variants. Individual specificities of anti-SARS-CoV-2 Abs and their impact on infectivity by other variants have been l...

Полное описание

Библиографические подробности

Главные авторы:	Frédéric Coutant, Franck Touret, Jean-Jacques Pin, Marina Alonzo, Cécile Baronti, Sandie Munier, Mikaël Attia, Xavier de Lamballerie, Tristan Ferry, Pierre Miossec
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Taylor & Francis Group 2024-12-01
Серии:	Emerging Microbes and Infections
Предметы:	COVID-19 B cell repertoire antibody-dependent enhancement human monoclonal antibody emerging variants
Online-ссылка:	https://www.tandfonline.com/doi/10.1080/22221751.2024.2307510
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!